Welcome to La Jolla Pharmaceutical Company
We are a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. We have several product candidates in development that we believe have been significantly de-risked. LJPC-501 is our proprietary formulation of angiotensin II, a naturally occurring regulator of blood pressure. LJPC-401 is our novel formulation of hepcidin, an endogenous peptide hormone that controls and regulates iron metabolism. LJPC-30Sa and LJPC-30Sb are La Jolla’s purified derivatives of gentamicin, an FDA-approved antibiotic.